CAR-T

Pinned Content Last updated 3 years ago

CAR-T therapies are progressing to the market at a much faster rate. Novartis just received approval from Australian authorities to make it's CAR-T therapy available to all eligible patients. Additionally, Bristol-Myers Squibb also received FDA approval in the US for it's CAR-T cell therapy for adults with relapsed large B-cell lymphoma. Kite Pharma already has FDA approved CAR-T cell therapy for the same in the market for a while now. Seems like all major Pharma/Biotech companies will soon embrace CAR-T's, leading to more competition and hopefully making these therapies more affordable as a result. Below is a link to the latest advancements in CAR-T's by biopharma reporter.
Links
https://www.biopharma-reporter.com/Article/2021/02/15/Scientific-breakthroughs-approvals-Latest-CAR-T-cell-therapy-related-developments#:~:text=Earlier%20this%20month%2C%20the%20US,directed%20CAR%20T%2Dcell%20immunotherapy.
Archived Board Archived Date Discussions
CAR-T's discussion 12
Archived Board Archived Date Discussions
CAR-T's discussion 12

4 members


Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now